ACHV (Achieve Life Sciences) FCF Yield % : -35.47 (As of Apr. 03, 2025)

View and export this data going back to 1995. Start your Free Trial

What is Achieve Life Sciences FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Achieve Life Sciences's Trailing 12-Month Free Cash Flow is $-29.77 Mil, and Market Cap is $83.94 Mil. Therefore, Achieve Life Sciences's FCF Yield % for today is -35.47%.

The historical rank and industry rank for Achieve Life Sciences's FCF Yield % or its related term are showing as below:

ACHV' s FCF Yield % Range Over the Past 10 Years
Min: -278.55 Med: 4228.37 Max: 23402.09
Current: -35.47

During the past 13 years, the highest FCF Yield % of Achieve Life Sciences was 23402.09%. The lowest was -278.55%. And the median was 4228.37%.

ACHV's FCF Yield % is ranked worse than
66.76% of 1498 companies
in the Biotechnology industry
Industry Median: -15.315 vs ACHV: -35.47

Achieve Life Sciences's FCF Margin % for the quarter that ended in Dec. 2024 was 0.00%.

Achieve Life Sciences FCF Yield % Historical Data

The historical data trend for Achieve Life Sciences's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Achieve Life Sciences FCF Yield % Chart

Achieve Life Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Yield %

Get a 7-Day Free Trial

-27.25

-40.03

-85.68

-28.10

-24.38

Achieve Life Sciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Yield %	Get a 7-Day Free Trial															-20.02	-13.59	-12.20	-25.45	-30.11

Competitive Comparison of Achieve Life Sciences's FCF Yield %

For the Biotechnology subindustry, Achieve Life Sciences's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Achieve Life Sciences's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Achieve Life Sciences's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Achieve Life Sciences's FCF Yield % falls into.

Save Embed

;

Save Embed

;

Achieve Life Sciences FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Achieve Life Sciences's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-29.77	/	122.0912
	=	-24.38%

Achieve Life Sciences's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-9.189	*	4	/	122.0912
	=	-30.11%

Achieve Life Sciences FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Achieve Life Sciences FCF Yield % Related Terms

Thank you for viewing the detailed overview of Achieve Life Sciences's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Achieve Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Achieve Life Sciences Inc (NAS:ACHV) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

SP4P:Germany SP4P:Germany

Address

22722 29th Drive SE, Suite 1000, Bothell, WA, USA, 98021

Website

https://www.achievelifesciences.com

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Executives

Richard Alistair Stewart	director, officer: President & CEO	19820 NORTH CREEK PARKWAY, SUITE 201, BOTHELL WA 98011
John Bencich	officer: CFO and PFO	2401 FOURTH AVENUE, SUITE 1050, SEATTLE WA 98121
Stuart Duty	director	22722 29TH DR SE, SUITE 100, BOTHELL WA 98021
Thomas Sellig	director	22722 29TH DR SE, SUITE 100, BOTHELL WA 98021
Thomas Braxton King	director	91 JAMES AVENUE, ATHERTON CA 94027
Dialectic Life Sciences Spv Llc	10 percent owner	C/O DIALECTIC LS MANAGER LLC, 119 ROWAYTON AVENUE, 2ND FLOOR, NORWALK CT 06853
Dialectic Ls Manager Llc	10 percent owner	119 ROWAYTON AVENUE, 2ND FLOOR, NORWALK CT 06853
John Fichthorn	10 percent owner	C/O DIALECTIC CAPITAL MANAGEMENT, LLC, 17 STATE STREET, SUITE 3930, NEW YORK NY 10004
Dialectic Capital Management, Lp	10 percent owner	119 ROWAYTON AVENUE, 2ND FLOOR, NORWALK CT 06853
Dialectic Partners, Llc	10 percent owner	2ND FLOOR 119 ROWAYTON AVE, NORWALK CT 06853
Vaughn B Himes	director	C/O SEATTLE GENETICS, INC., 21823 30TH DRIVE SE, BOTHELL WA 98021
Financial Group Svb	10 percent owner	2270 SAND HILL ROAD, MENLO PARK CA 94025
Svb Innovation Credit Partners Viii, Llc	10 percent owner	2770 SAND HILL ROAD, MENLO CITY CA 94025
Svb Innovation Credit Fund Viii, L.p.	10 percent owner	C/O SVB INNOVATION CREDIT PARTNERS VIII, 2770 SAND HILL ROAD, MENLO PARK CA 94025
Innovation Credit Fund Viii-a, L.p.	10 percent owner	2770 SAND HILL ROAD, MENLO PARK CA 94025